Yasmin and Hyperaesthesia - a phase IV clinical study of FDA data

Summary:

Hyperaesthesia is reported as a side effect among people who take Yasmin (drospirenone; ethinyl estradiol), especially for people who are female, 30-39 old, have been taking the drug for 6 - 12 months also take Paxil, and have Depression.

The phase IV clinical study analyzes which people have Hyperaesthesia when taking Yasmin. It is created by eHealthMe based on reports of 47,831 people who have side effects when taking Yasmin from the FDA, and is updated regularly.

What is Yasmin?

Yasmin has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 48,855 Yasmin users. Check the latest studies of Yasmin.

What is Hyperaesthesia?

Hyperaesthesia is found to be associated with 832 drugs and 916 conditions by eHealthMe. Check the latest studies of Hyperaesthesia.

On Jul, 17, 2026

47,831 people reported to have side effects when taking Yasmin.
Among them, 17 people (0.04%) have Hyperaesthesia.

Among these 17 people:

How long have people been on Yasmin when they have Hyperaesthesia? *

What is the gender of people who have Hyperaesthesia when taking Yasmin? *

female: 100 %
male: 0.0 %

What is the age of people who have Hyperaesthesia when taking Yasmin? *

What are other drugs people take besides Yasmin? *

Paxil: 6 people, 35.29%
Effexor: 5 people, 29.41%
Drospirenone And Ethinyl Estradiol: 3 people, 17.65%
Lexapro: 3 people, 17.65%
Mirena: 2 people, 11.76%
Folic Acid: 2 people, 11.76%
Buspar: 1 person, 5.88%
Cenestin: 1 person, 5.88%
Magnevist: 1 person, 5.88%
Lopressor: 1 person, 5.88%

What are other side effects people have besides Hyperaesthesia? *

Hypoaesthesia (reduced sense of touch or sensation): 6 people, 35.29%
Pulmonary Embolism (blockage of the main artery of the lung): 6 people, 35.29%
Head Injury: 5 people, 29.41%
Chest Pain: 5 people, 29.41%
Pain: 5 people, 29.41%
Limb Discomfort (discomfort in leg): 4 people, 23.53%
Skin Discoloration: 4 people, 23.53%
Weakness: 4 people, 23.53%
Stress And Anxiety: 4 people, 23.53%
Oedema Peripheral (superficial swelling): 3 people, 17.65%

What are the existing conditions these people have? *

Depression: 5 people, 29.41%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 11.76%
Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain): 2 people, 11.76%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 5.88%
Type 2 Diabetes: 1 person, 5.88%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 5.88%
Polyarthritis (arthritis which involves 5 or more joints simultaneously): 1 person, 5.88%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.88%
Indigestion: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Yasmin and have Hyperaesthesia?

- Check whether Hyperaesthesia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Yasmin:

Yasmin (48,855 reports)

Hyperaesthesia treatments and more:

Hyperaesthesia (10,827 reports)

How severe was Hyperaesthesia and when was it recovered:

Hyperaesthesia in Yasmin

Expand to all the drugs that have ingredients of drospirenone; ethinyl estradiol:

Hyperaesthesia and drugs with ingredients of drospirenone; ethinyl estradiol

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Yasmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperaesthesia:

Hyperaesthesia (832 drugs)

Browse all the conditions that are associated with Hyperaesthesia:

Hyperaesthesia (916 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on drospirenone; ethinyl estradiol (the active ingredients of Yasmin) and Yasmin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.